Compass Therapeutics, Inc. (CMPX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $30.64M | -29.5% |
| 2024 | $43.48M | +79.5% |
| 2023 | $24.23M | -30.7% |
| 2022 | $34.95M | -75.8% |
| 2021 | $144.51M | +207.0% |
| 2020 | $47.08M | +86.0% |
| 2019 | $25.30M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $30.64M | -29.5% |
| 2024 | $43.48M | +79.5% |
| 2023 | $24.23M | -30.7% |
| 2022 | $34.95M | -75.8% |
| 2021 | $144.51M | +207.0% |
| 2020 | $47.08M | +86.0% |
| 2019 | $25.30M | — |